In this study, PIM1 was shown to play a critical role in ccRCC progression, which is consistent with previous evidence showing that overexpression of PIM1 contributes to the progression of cancers, including breast cancer, mesothelioma and glioblastoma. Here, PIM1 is linked to breast cancer.